Nasal Drug Delivery System

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 66

Welcome!

NASAL

DRUG DELIVERY SYSTEM

CONTENTS
Novel Drug Delivery System

Global trends in drug delivery systems


Nasal Drug Delivery System Medical aspects Formulation Development Applications Conclusion

NOVEL DRUG DELIVERY SYSTEM - an overview

Novel drug delivery is one of the fastest growing healthcare sectors, with sales of drugs incorporating novel drug

delivery systems increasing @


an annual rate of 15%

By 2010, the US drug


delivery market alone will be worth $30 billion

There are great opportunities for companies


investing in R&D for new, improved drug delivery system, allowing for improved therapeutic absorption and efficacy in patients

Why Novel Drug


Delivery system? To optimize drugs therapeutic effect, convenience and dose To enhance a products life-cycle To improve `patient compliance

To target drug delivery To control overall healthcare costs


To facilitate biological drug delivery
7

The Novel Drug Delivery industry is comprised of

companies seeking to develop

Novel alternatives to existing delivery systems


Eg. implantable pumps

Enhancements to existing systems


Eg. sustained release oral dosage forms to
reduce dosing frequency

Commercially enabling delivery systems that provide


viable alternatives for therapeutics that are not fully developed and marketed because there are limited practical means of administration Eg. polar organics and other poorly absorbed therapeutics
8

Novel drug delivery companies have existed since the late 1960s, when Alza and Elan pioneered the oral methods of

enhanced drug delivery

The introduction of hypodermic devices but especially metered dose inhalers & nasal sprays, promoted the concept and absolute need for specific drug delivery

systems for specific diseases


9

Today there are between 300 & 350 companies worldwide with an interest in drug delivery, operating in a fierce environment where the number of drug launches

using proven delivery technology is growing

More novel technologies such as pulmonary delivery of insulin or needle-less human growth hormone

injections are under development and are yet to be


commercialized
10

Drug Delivery Systems

Oral

Injectable

Mucosal

Topical

Transdermal

Ocular

Vaginal/ Anal

Needle Needleless

Nasal Buccal Pulmonary

Active Passive

11

Global drug delivery market by administration mode


Nasal 2% Ocular 2% Injectable/ Implant 3% Transdermal 8% Inhalation 32% Oral 53%

12

13

Inhalation/pulmonary drug delivery system includes


Metered dose inhalers Dry powder inhalers Inhalation solutions & suspensions (for nebulizers) Inhalation nasal sprays

14

Historically, nasal drug delivery system has

received interest since ancient times

Therapy through intranasal administration has been


an accepted form of treatment in the Ayurvedic system of Indian medicine

15

Nasal Drug Delivery System

&
Opportunity
Annual market growth
Development time vis-a-vis new chemical entity Development cost vis-a-vis new chemical entity Merits Limitations

16

30%

11%

Annual growth of locally acting products

Annual growth of systemically acting products

17

Drug development time

10 14 years

New Chemical Entity

2 5 years

Nasal Drug Delivery

18

Drug development cost

$300-600 mio

New Chemical Entity

$50 mio

Nasal Drug Delivery

19

Merits
Avoidance of hepatic first-pass metabolism Rate of absorption comparable to IV

medication
Rapid onset of pharmacological action User-friendly, painless, non-invasive, needle-free administration mode

20

Merits...
Lower dose & hence lower side effects Useful for both local & systemic drug delivery

For CNS drugs, better site for rapid onset of action


Eg. Inhalation anesthesia, Morphine etc.

21

Limitations

Once administered, rapid removal of the


therapeutic agent from the site of absorption is difficult

Pathologic conditions such as cold or allergies


may alter significantly the nasal bioavailability

22

23

The respiratory tract, which includes the


nasal mucosa hypopharynx large airways & small airways

provides a relatively large mucosal surface area of

approx. 100 m2 (in normal adult) for drug absorption

24

Cross-sectional view Nasal site of drug spray & absorption Pathways for nasal absorption

25

Cross-sectional view

a nasal vestibule b palate c inferior turbinate

d middle turbinate e superior turbinate (olfactory mucosa) f nasopharynx

26

Site of drug spray & absorption

27

Pathways for nasal absorption


Absorption through the olfactory neurons - transneuronal absorption. Olfactory epithelium is considered as a portal for substances to enter CNS Absorption through the supporting cells & the surrounding capillary bed - venous drainage

Absorption into the cerebrospinal fluid

28

Transneuronal absorption

Olfactory nerve 1st cranial sensory nerve


29

Venous drainage

30

Nasal enzymes
Cytochrome P 450 dependent onooxygenases, Lactate dehydrogenase, Oxidoreductase, Hydrolases, Esterase, lactic dehydogenase, malic enzymes, lysosomal proteinases, steroid hydroxylases., etc., Cytochrome P450 dependent mono oxygenases has been reported to catalyse the metabolism of xenobiotics, nasal decongestants, nocotine, cocaine, phenacetin, nitrosamine progesterone etc., Insulin zinc free was hydrolysed slowly by leusine aminopeptidase, PG of E series was inactivated 15 hydroxyprostaglandin dehydrogenase
31

Nasal enzymes contd.,


Progesterone and testosterone were metabolized by several steroid hydroxylases in the nasal mucosa of rats

32

Nasal pH
Nasal secretion of adult : 5.5-6.5

Infants and children: 5-6.7


It becomes alkaline in conditions such as acute rhinitis, acute sinusitis. Lysozyme in the nasal secretion helps as antibacterial and its activity is diminished in alkaline pH

33

34

Therapeutic class of drugs


1. 2 adrenergic agonists

2. Corticosteroids
3. Antiviral 4. Antibiotics 5. Antifungal 6. More recently, vaccines

35

Drugs commonly administered through pulmonary route include 1. Terbutaline Sulphate - 2 adrenergic agonist 2. Salbutamol - 2 adrenergic agonist

3. Budesonide - corticosteroid
4. Ipratropium Bromide - anticholinergic 5. Sodium Chromoglycate mast cell stabilizer

36

Formulation Development

37

Formulation Development Dosage form Factors affecting drug absorption Formulation considerations

Physiological Pharmaceutical
38

Dosage forms

Liquid drop Liquid spray/nebulizers Aerosol Suspension spray/nebulizers Gel Sustained release

39

Drug concentration

Factors affecting drug absorption

Vehicle of drug delivery Mucosal contact time Degree of drugs ionization pH of the absorption site Size of the drug molecule Relative lipid solubility
40

Physiological effects
Drug metabolism in the respiratory tract &

reduction of systemic effect


Protein binding Mucociliary transport causing increased or decreased drug residence time

41

Physiological effects....

Local toxic effects of the drug


Eg., edema, cell injury, or altered tissue defenses

Local or systemic effects of propellants, preservatives, or carriers

42

Pharmaceutical

Physico-chemical properties of a drug candidate


Methods to enhance drug absorption Spray pump devices

43

1. Effect of particle size 2. Effect of molecular size 3. Effect of solution pH 4. Effect of drug lipophilicity 5. Effect of drug concentration

44

1. Effect of particle size


(aerodynamic size distribution) - Access to distal airways is a function of particle size - Large particles (> 7 microns) will be lost in the gastrointestinal tract - Small particles (< 3 microns) will be lost in exhaled breathe - Intermediate particles (3 to 7 microns) reach the actual site of action
45

2. Effect of molecular size


- Higher the molecular size, lower the nasal absorption

- A good systemic bioavailability can be achieved for molecules with a molecular weight of up to 1000 Daltons when no absorption enhancer is used

46

2. Effect of molecular size.....


- With the assistance of absorption enhancer, a good bioavailability can be extended to a molecular weight of at least 6000 Daltons Absorption enhancers: Polyacrylic acid Sodium Glycocholate

Sodium Deoxycholate
Polysorbate 80 etc.
47

3. Effect of solution pH
- Nasal absorption is pH dependent

- Absorption is higher at a pH lower than the dissociation constant (pKa) of the molecule - Absorption is lower as the pH increases beyond the dissociation constant

48

4. Effect of drug lipophilicity


- Polar (water soluble) drugs tend to remain on the

tissues of the upper airway


- Non-polar (lipid soluble) drugs are more likely to

reach distal airways


- Lipid soluble drugs are absorbed more rapidly

than water soluble drugs

49

5. Effect of drug concentration


- Absorption depends on the initial concentration of

the drug
- The absorption follows first-order kinetics

50

Methods to enhance nasal absorption of drugs

Structural modification
Salt or ester formation Formulation design

51

SPRAY PUMP DEVICES

- Unidose
- Bidose - Multidose

52

Bidose Unidose
53

Multidose

54

LEADING PUMP SUPPLIERS


Pfeiffer, Germany Valois, France Becton Dickinson, France Nemo, Spain

55

Applications
Delivery of non-peptide pharmaceuticals

Delivery of peptide-based pharmaceuticals

Delivery of diagnostic drugs

56

1. Delivery of non-peptide pharmaceuticals

Drugs with extensive pre-systemic metabolism, such as


- progesterone

- estradiol
- propranolol

- nitroglycerin
- sodium chromoglyate can be rapidly absorbed through the nasal mucosa with a systemic bioavailability of approximately 100%
57

2. Delivery of peptide-based pharmaceuticals


Peptides & proteins have a generally low oral

bioavailability because of their physico-chemical


instability and susceptibility to hepatogastrointestinal first-pass elimination Eg. Insulin, Calcitonin, Pituitary hormones etc. Nasal route is proving to be the best route for such

biotechnological products

58

3. Delivery of diagnostic drugs

Diagnostic agents such as

Phenolsulfonphthalein kidney function


Secretin pancreatic disorders

Pentagastrin secretory function of gastric acid

59

60

Nasal route is a part of drug delivery strategy that is emerging to be a fastest growing drug delivery system with an annual growth of 11% for locally acting drugs & 30% for systemically acting drugs

61

Nasal drug delivery offers such benefits as Rapid onset of action with lower dose & minimal side effects Has an advantage of site-specific delivery with improved therapeutic effects

62

Attractive for delicate molecules allowing systemic administration

without significant degradation

63

Nasal drug delivery system offers flexibility for multiple formulations ranging from nasal drop to suspension spray

64

Recent activities indicate a bright prospect for site-specific delivery of biotechnological products such as Insulin & other hormones

65

66

You might also like